Coppen A, et al. “Enhancement of the Antidepressant Action of Fluoxetine by Folic Acid: A Randomised, Placebo Controlled Trial,” Journal of Affective Disorders (November 2000): Vol. 60, No. 2, pp. 121–30. www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10967371

Freeman MP, et al. “Complementary and Alternative Medicine in Major Depressive Disorder: The American Psychiatric Association Task Force Report,” Journal of Clinical Psychiatry (June 2010): Vol. 71, No. 6, pp. 669–81. www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=20573326

Gaynes BN, et al. “The STAR*D study: Treating Depression in the Real World,” Cleveland Clinic Journal of Medicine (January 2008): Vol. 75, No. 1, pp. 57–66. www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=18236731

Kocsis JH, et al. “Cognitive Behavioral Analysis System of Psychotherapy and Brief Supportive Psychotherapy for Augmentation of Antidepressant Nonresponse in Chronic Depression: The REVAMP Trial,” Archives of General Psychiatry (November 2009): Vol. 66, No. 11, pp. 1178–88. www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=19884606

Nelson JC, et al. “Atypical Antipsychotic Augmentation in Major Depressive Disorder: A Meta-Analysis of Placebo-Controlled Randomized Trials,” American Journal of Psychiatry (September 2009): Vol. 166, No. 9, pp. 980–91. www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=19687129

Nelson JC. “S-Adenosyl Methionine (SAMe) Augmentation in Major Depressive Disorder,” American Journal of Psychiatry (August 2010): Vol. 167, No. 8, pp. 889–91. www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=20693465

Nierenberg AA, et al. “A Critical Overview of the Pharmacologic Management of Treatment-Resistant Depression,” Psychiatric Clinics of North America (March 2007): Vol. 30, No. 1, pp. 13–29. www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=17362800

Papakostas GI, et al. “S-Adenosyl Methionine (SAMe) Augmentation of Serotonin Reuptake Inhibitors for Antidepressant Nonresponders with Major Depressive Disorder: A Double-Blind, Randomized Clinical Trial,” American Journal of Psychiatry (August 2010): Vol. 167, No. 8, pp. 942–48. www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=20595412

Peet M, et al. “A Dose-Ranging Study of the Effects of Ethyl-Eicosapentaenoate in Patients with Ongoing Depression Despite Apparently Adequate Treatment with Standard Drugs,” Archives of General Psychiatry (October 2002): Vol. 59, No. 10, pp. 913–19. www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12365878

Rush AJ, et al. “Bupropion-SR, Sertraline, or Venlafaxine-XR after Failure of SSRIs for Depression,” New England Journal of Medicine (March 23, 2006): Vol. 354, No. 12, pp. 1231–42. www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16554525

Rush AJ, et al. “STAR*D: Revising Conventional Wisdom,” CNS Drugs (August 1, 2009): Vol. 23, No. 8, pp. 627–47. www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=19594193

Shelton RC, et al. “Therapeutic Options for Treatment-Resistant Depression,” CNS Drugs (February 1, 2010): Vol. 24, No. 2, pp. 131–61. www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=20088620

Thase ME, et al. “Cognitive Therapy Versus Medication in Augmentation and Switch Strategies as Second-Step Treatments: A STAR*D Report,” American Journal of Psychiatry (May 2007): Vol. 164, No. 5, pp. 739–52. www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=17475733